Evidence for a causal association with thrombocytopenia among 102 drugs analyzed by all 3 methods
| Result . | No. of drugs (N = 102) . |
|---|---|
| Evidence by all 3 methods | 23 |
| Evidence by case reports and laboratory | 1 |
| Evidence by case reports and AERS | 16 |
| Evidence by laboratory and AERS | 15 |
| Evidence by case reports only | 3 |
| Evidence by laboratory only | 5 |
| Evidence only by AERS | 25 |
| No evidence by any method | 14 |
| Result . | No. of drugs (N = 102) . |
|---|---|
| Evidence by all 3 methods | 23 |
| Evidence by case reports and laboratory | 1 |
| Evidence by case reports and AERS | 16 |
| Evidence by laboratory and AERS | 15 |
| Evidence by case reports only | 3 |
| Evidence by laboratory only | 5 |
| Evidence only by AERS | 25 |
| No evidence by any method | 14 |
The 3 methods of analysis were (1) case reports, (2) laboratory identification of drug-dependent, platelet-reactive antibodies, and (3) data mining of the FDA AERS database.